Advanced Search

Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2007 June;59(3) > Minerva Pediatrica 2007 June;59(3):207-13

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532

 

Minerva Pediatrica 2007 June;59(3):207-13

 ORIGINAL ARTICLES

Diagnostic problems and postnatal follow-up in congenital toxoplasmosis

Mazzola A. 1, Casuccio A. 2, Romano A. 1, Schimmenti M. G. 1, Titone L. 3, Di Carlo P. 3

1 ARNAS Civico Benfratelli G. Di Cristina and M. Ascoli, Palermo, Italy
2 Section of Ophthalmology Departments of Neurology, Ophthalmology Otorhinolaryngology and Psychiatry (Di.N.O.O.P.) University of Palermo, Palermo, Italy
3 Institute of Infectious Diseases University of Palermo, Palermo, Italy

Aim. In order to assess the consequences of different clinical approaches in the prenatal management of congenital toxoplasmosis, we retrospectively reviewed 58 pregnant women with Toxoplasma seroconversion and prospectively enrolled their 59 infants, referred to us from 1999 to 2004.
Methods. Data on clinical, laboratory and demographic characteristics of the pregnant women were collected. Their children were entered into a 48-month follow-up programme in which clinical, instrumental, ophthalmologic and serologic evaluations were carried out at birth, at 1, 3, 6, 9, 15, 18, 24, 36 and at 48 months of life. Paediatric treatment with Spiramycin alone or alternated with Pyrime-thamine-Sulphadiazine was administered according to the different clinical cases.
Results. Time of infection was dated in the first trimester for 24 women (41%), in the second trimester for 18 women (31%) and in the third trimester for 16 (28%). In the first trimester of pregnancy 20 of the 24 infected women had undergone amniocentesis, while the test had not been performed on any of the women infected in the third trimester. Serological follow-up revealed that 11 (19%) of the infants had been infected. An alternating regimen with Pyrimethamine-Sulphadoxine was administered to the infected children. All the infants were clinically asymptomatic, and the instrumental follow-up revealed specific toxoplasmosis anomalies in 4/11 infected children.
Conclusion. Our results highlight issues and problems concerning current prenatal diagnostic tests and the therapeutic approach based on PCR testing of amniotic fluid alone. The incidence of ocular-cerebral lesions observed in children born to women with seroconversion in the third trimester raises questions about the diagnostic and therapeutic approach for these women and their offspring. Paediatric therapeutic protocol, with alternating Pyrime-thamine-Sulphadiazine regimen, applied also to asymptomatic children born to women with inadequate prenatal diagnostic management, could prevent severe sequelae.

language: English


FULL TEXT  REPRINTS

top of page